AAPS Keynote Philadelphia
In this presentation, Nancy describes how %CV is an often used, but poor metric for relating assay performance, reported value measurement uncertainty and fitness-for-purpose. She presents a biomarker case study to show how assay suitability is inextricably linked to a statistical hypothesis framework and demonstrates how assay validation data can be used to define and evaluate assay performance criteria.
